These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38056042)
1. The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation. Hong S; Shinya Y; Trejo-Lopez JA; Gruber LM; Erickson D; Bendok BR; Chaichana KL; Atkinson JL; Marino MJ; Donaldson AM; Stokken JK; Westphal SA; Chang AY; Samson SL; Choby GW; Van Gompel JJ Clin Neurol Neurosurg; 2024 Jan; 236():108075. PubMed ID: 38056042 [TBL] [Abstract][Full Text] [Related]
2. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Asa SL; Mete O; Riddle ND; Perry A Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858 [TBL] [Abstract][Full Text] [Related]
3. Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. Peng G; Guo C; Lv Y; Li D; Zhou L; Shen R; Chen Y; Zheng X; Sun Z; Zheng H; Long M BMC Endocr Disord; 2022 Dec; 22(1):325. PubMed ID: 36539773 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of pituitary adenomas. Chanson P; Salenave S Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032 [TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center Experience. Heo J; Suh YL; Kim SH; Kong DS; Nam DH; Lee WJ; Kim ST; Hong SD; Ryu S; Lee YB; Kim G; Jin SM; Kim JH; Hur KY Endocrinol Metab (Seoul); 2024 Apr; 39(2):387-396. PubMed ID: 38311828 [TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study. Mo C; Chen H; Xu J; Guo Y; Wang Y; Li Z; Tong T; Gui S; Zhong L Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455 [TBL] [Abstract][Full Text] [Related]
7. [The Tips of the Endocrine Assessment in the Case of Pituitary Tumor]. Terasaka T; Inagaki K No Shinkei Geka; 2023 Jul; 51(4):625-633. PubMed ID: 37491059 [TBL] [Abstract][Full Text] [Related]
8. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors. Seo H; Refetoff S; Fang VS Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
11. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings. Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin. Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581 [TBL] [Abstract][Full Text] [Related]
13. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method. Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563 [TBL] [Abstract][Full Text] [Related]
14. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [TBL] [Abstract][Full Text] [Related]
15. Rarity of PIT1 involvement in children from Russia with combined pituitary hormone deficiency. Fofanova OV; Takamura N; Kinoshita E; Yoshimoto M; Tsuji Y; Peterkova VA; Evgrafov OV; Dedov II; Goncharov NP; Yamashita S Am J Med Genet; 1998 Jun; 77(5):360-5. PubMed ID: 9632165 [TBL] [Abstract][Full Text] [Related]
17. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly. Nyquist P; Laws ER; Elliott E Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823 [TBL] [Abstract][Full Text] [Related]
18. Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis. Caglar AS; Kapucu A; Dar KA; Ozkaya HM; Caglar E; Ince H; Kadioglu P Endocrine; 2015 Aug; 49(3):761-8. PubMed ID: 25697985 [TBL] [Abstract][Full Text] [Related]
19. The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations. Dumitriu-Stan RI; Burcea IF; Nastase VN; Ceaușu RA; Dumitrascu A; Cocosila LC; Bastian A; Zurac S; Raica M; Poiana C Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003353 [TBL] [Abstract][Full Text] [Related]
20. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line. Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]